MTCO1P2

Across TCGA pan-cancer cohorts, MTCO1P2 RNA is linked to patient survival in 23 of 34 cancer types, making it the most broadly survival-associated MTCO1P2 data layer.

The strongest signal is observed in adrenocortical carcinoma (ACC), where higher MTCO1P2 RNA is associated with better overall survival. In most high-consensus cancer types, elevated MTCO1P2 expression acts as an unfavorable survival marker, although some lineages such as ACC and KICH show a favorable association.

ACC, KICH, and KIRC are the cancer types where MTCO1P2 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
ACC	OS	Median	All	0.970	0.773	<.001	98	view →
KICH	OS	Median	II,III,IV	1.000	0.571	.001	86	view →
KIRC	DFS	Quartile	IV	0.614	0.238	.003	48	view →
UCS	DFS	Median	IV	0.885	0.440	.015	30	view →
UCEC	DFS	Tertile	II,III,IV	0.801	0.887	.011	30	view →
BLCA	DFS	Tertile	II,III,IV	0.704	0.590	.011	29	view →
CESC	DFS	Median	II,III,IV	0.791	0.600	.007	26	view →
UVM	DFS	Median	III,IV	0.195	0.752	.002	25	view →
HNSC	DFS	Tertile	IV	0.529	0.302	.002	24	view →
LUAD	OS	Tertile	III,IV	0.348	0.715	.004	19	view →
DLBC	DFS	Quartile	All	0.251	1.000	.003	18	view →
KIRP	DFS	Median	II,III,IV	0.912	0.326	.006	18	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 23 lineages.

MTCO1P2–ACC (OS)

Open the ACC breakdown →